H&N Overview on oncologic therapy Flashcards

1
Q

What defines the ratio of therapy resulting in
therapeutic effect to the amount that results in
toxicity or mortality?

A

Therapeutic ratio or index

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What type of treatment regimen uses only surgery

or radiation therapy for curative intent?

A

Single-modality treatment. Any approach using more than
one treatment modality is considered multimodality or
combined modality.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What treatment approach uses chemotherapy

and/or radiation therapy before definitive therapy?

A

Neoadjuvant/Induction therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What treatment approach uses chemotherapy and radiation therapy together as the primary treat-
ment modality?

A

Concurrent (concomitant) therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What treatment approach uses radiation therapy
with or without chemotherapy after primary
surgical management?

A

Adjuvant therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What treatment approach uses surgery, chemo-
therapy, and/or radiation for patients with recur-
rent or metastatic disease without the intent to cure? With the intent to cure?

A

● Palliative therapy

● Salvage therapy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Define the three types of clinical trials.

A

● Phase I: Defines the maximum tolerated dose or safety of a drug or invasive medical device
● Phase II: Includes more patients than phase I; assesses the efficacy and side effects or toxicity associated with the intervention of interest
● Phase III: Randomized prospective trial comparing the
intervention of interest with the standard of care; at
termination, can be considered for Food and Drug
Administration approval for the intervention of interest.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What tumors are considered by the National
Comprehensive Cancer Network (NCCN, 2011) to
be very advanced and therefore managed with a
unique algorithm regardless of tumor subsite?

A

T4b, any N, M0 or unresectable nodal disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

The NCCN (2011) recommends either a clinical
trial or standard therapy for patients diagnosed
with very advanced head and neck cancer. How is
standard therapy individualized, and what does it
include?

A

ECOG performance status (PS):
● PS 0–1: Concurrent chemoradiation therapy with cisplatin
or induction chemotherapy followed by radiation or
chemoradiation therapy
● PS 2: Definitive radiation therapy or concurrent chemo-
radiation therapy
● PS 3: Radiation therapy vs. single-agent chemotherapy vs.
best supportive care
Note: With improvement in surgical management recon-
structive techniques, some authorities suggest that surgical
management should be considered for some T4b tumors.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patients with recurrent or persistent head and
neck cancer after primary management are
considered by the NCCN (2011) to have very
advanced head and neck cancer. For patients who
do not have distant metastases, what are the
treatment options?

A

● Locoregional recurrence without prior radiation therapy
○ Resectable: Surgery ± adjuvant therapy (for adverse
risk features) vs. primary chemoradiation therapy
○ Unresectable: individualized based on performance
status to nonsurgical treatment
● Locoregional recurrence or second primary with a history
of prior radiation therapy
○ Resectable: Surgery ± reirradiation ± chemotherapy
○ Unresectable: Reirradiation ± chemotherapy vs. pallia-
tive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the standard therapy recommended by
the NCCN (2011) for metastatic head and neck
cancer?

A

Based on ECOG performance status (PS):
● PS 0–1: Combination or single agent chemotherapy →
best supportive care
● PS 2: Single-agent chemotherapy or best supportive care
→ best supportive care
● PS 3: Best supportive care

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What percentage of patients with locally advanced
head and neck squamous cell carcinoma die from
recurrent locoregional disease within five years of
initial treatment?

A

30 to 50%

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is the median length of survival for a patient
diagnosed with locally advanced or metastatic
head and neck squamous cell carcinoma?

A

6 to 9 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are the primary goals of palliative therapy?

A

● Improve quality of life

● Prolong life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What prognostic factors predict poor outcome for
patients with incurable head and neck squamous
cell carcinoma?

A
● Poor performance status
● Extensive tumor burden
● Malnutrition
● Prior history of extensive definitive therapeutic intervention
● Rapid recurrence or progression
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the general surveillance schedule for
history of physical examination and imaging as
recommended by the NCCN (2011) for head and
neck cancer?

A

History and physical examination
● Year 1: Every 1 to 3 months
● Year 2: Every 2 to 4 months
● Year 3 to 5: Every 4 to 6 months
● > 5 years: Every 6 to 12 months
Imaging
● Within 6 months of treatment end for T3–4 or N2–3
cancers of the oropharynx, hypopharynx, glottic larynx,
supraglottic larynx, and nasopharynx
● Additional imaging based on concerning signs and
symptoms

17
Q

When should you evaluate a patient’s thyroid-stimulating hormone (TSH) level after completion of treatment for head and neck cancer?

A

If the neck was irradiated, check a TSH every 6 to 12 months.

18
Q

What are the three functional outcomes that are
most commonly assessed for head and neck
cancer?

A

● Airway
● Speech
● Swallowing

19
Q

What focuses on a patient’s perception of the

impact of illness before, during, and after treatment?

A

Health-related quality of life

20
Q

What domains are generally included in health

related quality of life?

A

● Physical/somatic
● Functional
● Social
● Psychological/emotional